Salvia officinalis extract in the treatment of mild to moderate Alzheimer's Disease: A placebo-controlled, randomized and double blind clinical trial.
New treatments were presented for management of Alzheimer's Disease (AD) in the recent years. However, they were not fully successful. The objective of this study was to assess the efficacy and safety of Salvia officinalis extract in AD at 4 months using fixed dose of the extract. A randomized,...
Saved in:
Main Authors: | Sh Akhondzadeh (Author), M Norouzian (Author), MR Mohammadi (Author), S Ohadinia (Author), AH Jamshidi (Author), M Khani (Author) |
---|---|
Format: | Book |
Published: |
Institue of Medicinal Plants, ACECR,
2002-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melissa officinalis L. extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial
by: S Akhondzadeh, et al.
Published: (2002) -
Comparison of Lavandula officinalis tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized pilot study
by: M Khani, et al.
Published: (2002) -
Crocus sativus L. in the treatment of mild to moderate depression: A double-blind, randomised and placebo controlled trial
by: AA Noorbala, et al.
Published: (2004) -
Comparison of dried ethanolic extract of Croucus sativus L. and imipramine in the treatment of mild to moderate depression: a double-blind, randomised trial
by: SH Akhondzadeh, et al.
Published: (2003) -
Comparison of <it>Crocus sativus L</it>. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]
by: Jamshidi Amir-Hossein, et al.
Published: (2004)